<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In this randomized prospective study, we included 30 patients with different <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> (<z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> or severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>) to compare peripheral blood stem cells (PBSC) (15 patients; mean age 23) and bone marrow (BM) (15 patients; mean age 21.8) as a source for allogeneic transplantation regarding the tempo of hematopoietic recovery and the incidence of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> (GVHD) </plain></SENT>
<SENT sid="1" pm="."><plain>In the BM group, the median nucleated cell count harvested was 1.3 x 10(10), while in the PBSC group, the aphereses contained a median of 4.4 x 10(6) CD34+/kg recipient weight </plain></SENT>
<SENT sid="2" pm="."><plain>PBSC transplantation (PBSCT) was associated with faster hematopoietic reconstitution measured as absolute neutrophil count (ANC) &gt;0.5 x 10(9)/l (log-rank P value &lt;0.0018) and platelet count &gt;25 x 10(9)/l (log-rank P value &lt;0.0098) </plain></SENT>
<SENT sid="3" pm="."><plain>Seven patients (46.7%) in the BM group vs only one patient (6.7%) in the PBSC group developed <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD (P = 0.013) </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore, we conclude that PBSCT is associated with faster hematopoietic recovery and the incidence of <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD does not exceed that seen with BMT </plain></SENT>
</text></document>